Fidelity Investments
SER icon

Fidelity Investments’s Serina Therapeutics SER Stock Holding History

Fidelity Investments’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$8 – 5527
2025
Q1 		$8 Buy
+1
New +$5 ﹤0.01% 5256
2022
Q2 		– Sell
-152
Closed -$5K – 5568
2022
Q1 		$5K Buy
+152
New +$4.33K ﹤0.01% 4458
2021
Q4 		– Hold
0
– – – 5014
2019
Q4 		– Sell
-28
Closed -$2K – 4329
2019
Q3 		$2K Buy
+28
New +$2.66K ﹤0.01% 3589

Other funds holding SER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
WA
Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Fidelity Investments's SER Position: Q2 2025 in Review

Fidelity Investments sold out of Serina Therapeutics (SER) in Q2 2025, closing a stake of 1 share — an estimated $8 sold.

Fidelity Investments first reported a position in SER in Q3 2019 and held it in 3 quarters. The position peaked at $5K in Q1 2022. 23 funds tracked by Wall St. Rank hold SER as of Q2 2025.

  • Fidelity Investments reported no remaining Serina Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Fidelity Investments sold 1 Serina Therapeutics share in Q2 2025, an estimated $8.
  • Fidelity Investments first reported a position in Serina Therapeutics in Q3 2019 and held it in 3 quarters.
  • Fidelity Investments's Serina Therapeutics position peaked at $5K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.